Clinical trial

Sotatercept in Pulmonary Arterial Hypertension

NCT07140484

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-10-06

PhasePHASE4

Study timeline

Study start (actual)2025-10-06Date precision: day

Registry last updated2026-07-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Artery Hypertensionunresolved

Interventions

SotaterceptDRUG · verified · RxNorm: sotatercept

Sponsors & collaborators

University of Albertalead sponsor

Merck Canada Inc.collaborator

Alberta Health servicescollaborator

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07140484 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.